Diabetes & metabolic medicine, Johannesburg
Type 2 diabetes care in Johannesburg.
Doctor-led type 2 diabetes care that considers glucose control, cardiovascular and kidney risk, weight, medication and the wider health of each patient.
In short
Type 2 diabetes is a chronic metabolic disease defined by persistent hyperglycaemia, usually driven by a combination of insulin resistance and progressive loss of pancreatic beta-cell function. Good care is not only about lowering HbA1c. Modern diabetes management also addresses cardiovascular risk, kidney health, weight, blood pressure, lipids, smoking, medication burden and complications, with treatment individualised to the patient's risks and priorities.
Medically reviewed by Dr Arnav Kapur, MBBCh Cum Laude
The approach
Understand first. Then treat.
A single glucose target does not capture the whole disease. Two people with the same HbA1c can have very different cardiovascular, kidney, weight and hypoglycaemia risks, so treatment should be built around the individual rather than a universal ladder.
At MLI, many uncomplicated or early metabolic cases can begin with Dr Arnav Kapur. Complex diabetes, difficult control or specialist-level endocrine problems can be escalated internally to Dr Sindeep Bhana.
What diabetes care may include
- HbA1c and glucose pattern
- Current medication, adherence and side effects
- Weight, waist and body composition
- Blood pressure
- Lipid profile and cardiovascular risk
- Kidney function and urine albumin-to-creatinine ratio where appropriate
- Liver and metabolic-dysfunction context
- Smoking, alcohol, nutrition and physical activity
- Retinopathy, neuropathy and foot-care screening prompts
- Hypoglycaemia risk
- Sleep and obstructive sleep-apnoea risk where relevant
- Specialist endocrinology when control is difficult or the diagnosis is atypical
HbA1c is important, but it is not the whole plan
HbA1c remains a central measure of average glycaemia, but treatment targets are individualised according to age, comorbidity, hypoglycaemia risk, duration of diabetes and patient priorities. Blood pressure, lipids, kidney health, smoking and weight often contribute as much to long-term outcomes as glucose itself.
Choose medication for the patient, not just the number
Current diabetes care increasingly selects medication according to the whole clinical picture. Metformin remains useful for many patients, while GLP-1-based therapy, SGLT2 inhibitors and other agents may be chosen when weight, cardiovascular disease, kidney disease or hypoglycaemia risk make them particularly relevant. Treatment is adjusted according to contraindications, tolerability, access and individual goals.
Weight and muscle matter
For patients with excess adiposity, meaningful weight loss can improve glycaemia, blood pressure, liver health and medication requirements. During weight reduction, preserving skeletal muscle with resistance training and adequate nutrition is important, particularly when GLP-1-based treatment is used.
Know when diabetes needs specialist endocrinology
Most type 2 diabetes can be managed effectively in general medical care, but specialist input becomes valuable when control remains difficult despite appropriate treatment, the diagnosis is uncertain, recurrent hypoglycaemia occurs, insulin management becomes complex, or another endocrine disorder may be contributing.
Common questions
Answers before you book.
Can type 2 diabetes go into remission?
Some people, particularly earlier in the disease and after substantial sustained weight loss, can achieve glucose values below the diabetes threshold without glucose-lowering medication for a period of time. 'Remission' is the preferred term rather than cure, because relapse can occur and ongoing follow-up remains important.
Do all people with type 2 diabetes need insulin?
No. Many people can be managed for years without insulin, depending on beta-cell function, glucose levels, comorbidities and other medication options. Insulin is appropriate when needed and should not be framed as failure.
Are GLP-1 medicines useful in diabetes?
Yes, in appropriately selected patients. They can improve glycaemia and support weight loss, and some agents have established cardiovascular benefit. The specific choice depends on indication, comorbidity, tolerability, contraindications, availability and cost.
How often should diabetes be reviewed?
The interval depends on control and treatment changes. Patients with medication changes or poor control need closer follow-up, while stable patients can be reviewed less frequently. HbA1c, kidney risk, blood pressure and complication screening are monitored according to clinical need and guideline intervals.
This page provides general health information and does not replace individual diagnosis or treatment. Diabetes medication and treatment targets are individualised according to clinical context.
Ready to start properly?
- Metabolic Health & Diabetes Consultation
- Prediabetes
- Insulin Resistance
- Medical Weight Management
- Cardiovascular Risk Assessment
- Specialist Endocrinology
- Longevity & Preventative Medicine
Centre of Advanced Medicine · 13 Scott Street, Waverley, Johannesburg
Monday to Friday, 07:40 to 17:00
011 440 8721